Spark Therapeutics, Inc. Common Stock
ONCE
ONCE was delisted on the 16th of December, 2019.
127 hedge funds and large institutions have $1.71B invested in Spark Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 37 reducing their positions, and 10 closing their positions.
129% more call options, than puts
Call options by funds: $8.66M | Put options by funds: $3.78M
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
41% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 37
15% more capital invested
Capital invested by funds: $1.48B → $1.71B (+$224M)
4% more funds holding
Funds holding: 122 → 127 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$44M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$28.9M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$17.3M |
| 4 |
BlackRock
New York
|
+$11.9M |
| 5 |
IPLA
Ice Pond Lane Advisers
New York
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$25M |
| 2 |
DM
Deerfield Management
New York
|
-$15.1M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$12.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.2M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$9.22M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHK
126
Point72 Hong Kong
Hong Kong
| $1K | +$503 | +9 | New |
|
|
IWM
127
IHT Wealth Management
Chicago,
Illinois
| $30 | – | – | – |
|
|
DM
128
Deerfield Management
New York
| – | -$15.1M | -283,000 | Closed |
|
|
BCPEM
129
Bain Capital Public Equity Management
Boston,
Massachusetts
| – | -$12.2M | -228,517 | Closed |
|
130
Squarepoint
New York
| – | -$488K | -9,151 | Closed |
|
|
GGHC
131
Gilder Gagnon Howe & Co
New York
| – | -$367K | -6,887 | Closed |
|
132
Simplex Trading
Chicago,
Illinois
| – | -$223K | -3,986 | Closed |
|
|
QT
133
Quantbot Technologies
New York
| – | -$92K | -1,741 | Closed |
|
|
SIAP
134
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
| – | -$16K | -300 | Closed |
|
|
TRCT
135
Tower Research Capital (TRC)
New York
| – | -$16K | -300 | Closed |
|
|
HMS
136
Hanseatic Management Services
Albuquerque,
New Mexico
| – | -$1K | -20 | Closed |
|
ONCE Hedge Fund Activity: Q2 2017 in Review
127 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q2 2017, worth a combined $1.71B — up 15% from $1.48B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ONCE positions and 10 closed out — a net gain of 7 holders — while 52 added to existing stakes and 37 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $44M. The largest seller was American Century Companies, cutting an estimated $25M.
- 127 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q2 2017, up from 122 in Q1 2017.
- Funds reported $1.71B of Spark Therapeutics, Inc. Common Stock stock for Q2 2017, up 15% quarter-over-quarter.
- 17 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q2 2017 and 10 closed out, a net change of +7 holders.
- The largest Spark Therapeutics, Inc. Common Stock buyer in Q2 2017 was Citadel Advisors, an estimated $44M added.
- The largest Spark Therapeutics, Inc. Common Stock seller in Q2 2017 was American Century Companies, an estimated $25M sold.
Based on aggregated 13F filings for Q2 2017.